HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neutrogena Growth Rests In Existing Categories - CEO McNamara

This article was originally published in The Rose Sheet

Executive Summary

Neutrogena's double-digit growth strategy calls for product expansion in existing categories, with new introductions that extend the company's foundation of products "grounded in real results for both the health and beauty of skin and hair," CEO Michael McNamara said.

You may also be interested in...



J&J Worldwide Skin Care Crosses $1.5 Bil. Mark In 2000

Johnson & Johnson's flourishing skin care business, which saw double-digit increases in the U.S. for both the 2000 fourth quarter and full year, remains the brightest performer in the firm's consumer sector.

J&J Worldwide Skin Care Crosses $1.5 Bil. Mark In 2000

Johnson & Johnson's flourishing skin care business, which saw double-digit increases in the U.S. for both the 2000 fourth quarter and full year, remains the brightest performer in the firm's consumer sector.

P&G Takes "Gamble" Out Of Stock Price, Shares Jump 17% In Third Quarter

Procter & Gamble's decision to whittle product categories and redirect business initiatives to core brands illustrates a movement among H&BA diversifieds that appears to be winning credibility with investors.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel